Quantcast
Last updated on April 18, 2014 at 16:41 EDT

Latest radiation therapy Stories

2013-12-15 23:00:29

In Response to Dr. Oz Dec, 6th Show on cell phone radiation causing breast cancer. RF Safe adds pink to the colors of their line of RF radiation shielded cell phone pouches for breast cancer awareness. Palo Alto, CA (PRWEB) December 15, 2013 Dr. Oz said women who keep their cell phones in their bras are putting themselves at risk for breast cancer. On the Dec. 6 episode of the Dr. Oz Show ("Why You Should Keep Your Cell Phone Out of Your Bra"), Dr. Oz said he believes...

2013-12-13 13:32:33

ESMO releases position paper on the role of medical oncologists in cancer care to ensure patient's access to optimal care Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says. Medical oncologists are specialist cancer physicians trained to provide treatment with drugs, spanning from the old one-fits-all chemotherapy to newer targeted agents or...

2013-12-13 12:23:17

Data presented at the 2013 San Antonio Breast Cancer Symposium CLEVELAND, Dec. 13, 2013 /PRNewswire/ -- New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer tumors after brief exposure to either biologic therapy or chemotherapy can predict future clinical outcomes in patients. Results showed that through deep...

2013-12-13 08:25:26

NEW YORK, Dec. 13, 2013 /PRNewswire/ -- The first Esteya® electronic brachytherapy system in the United States has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer treatment that relies on a small, high dose rate (HDR) X-ray source to apply high precision radiotherapy directly to the cancer site. "With support from Elekta, Memorial Sloan-Kettering will lead a multicenter clinical study...

2013-12-13 04:20:44

LUGANO, Switzerland, December 13, 2013 /PRNewswire/ -- ESMO releases position paper on medical oncologist's role Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says [http://annonc.oxfordjournals.org/content/early/2013/12/13/annonc.mdt522.full.pdf+html ]. (Photo: http://photos.prnewswire.com/prnh/20131128/654773)...

2013-12-11 08:29:17

Study evaluates eliminating coiling by using the novel anti-reflux Surefire Infusion System in radioembolization procedures WESTMINSTER, Colo., Dec. 11, 2013 /PRNewswire/ -- Surefire Medical, Inc. today announced that it has completed enrollment in the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial. This randomized prospective study investigates the feasibility and benefits of performing Selective Internal Radiation Therapy (SIRT), or radioembolization, without...

2013-12-10 23:25:18

Ability to customize radiation therapy improves patient safety & quality. Aliso Viejo, Calif. (PRWEB) December 10, 2013 Cianna Medical, Inc., a women’s health company, today announced the outcomes of a large, retrospective study demonstrating the safety and efficacy of the SAVI® breast brachytherapy applicator. Researchers reported favorably low recurrence rates, high rates of survival and excellent cosmetic outcomes. SAVI is a strut-based applicator that delivers a form of...

2013-12-09 12:26:41

- Radiation therapy leaders call for comprehensive payment reform to improve the quality of care for life-saving cancer care - WASHINGTON, Dec. 9, 2013 /PRNewswire-USNewswire/ -- The Radiation Therapy Alliance (RTA) - a nonprofit organization representing 227 community-based radiation therapy centers - today commended the Centers for Medicare and Medicaid Services (CMS) for withdrawing the proposal to cap certain freestanding radiation oncology reimbursements at the OPD/ASC rates...

2013-12-06 16:23:33

HOUSTON, Dec. 6, 2013 /PRNewswire/ -- C4 Imaging LLC is pleased to announce U.S. Food and Drug Administration 510(k) clearance of its first product, the Sirius(TM) MRI Marker. The novel Positive-Signal MRI Marker will be used following treatment of prostate cancer with brachytherapy to facilitate seed localization within the prostate, utilizing a single post-implant Magnetic Resonance (MR) imaging procedure. Brachytherapy, or radioactive seed implantation, is a standard option for the...

2013-12-06 11:11:38

Tumor cells temporarily lose mutation to evade drugs targeting mutation A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped. The...